Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conservative Treatments of Retinoblastoma

NCT02866136 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02866136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conservative Treatments of Retinoblastoma
Lead sponsor
Institut Curie
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 29, 2012
Completion date
September 30, 2035
Enrollment
133 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

children, retinal neoplasm, retinoblastoma